Detection of high-risk human papillomavirus type 16 and 18 using isothermal helicase-dependent amplification

Diagnostic Microbiology and Infectious Disease

Volumn 79, Issue 2, 2014, Pages 178-182

  Barbieri, Daniela ^a,b   Venturoli, Simona ^a   Rösl, Frank ^b   Rincon Orozco, Bladimiro ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cervical cancer; Cost effective method; HPV detection; Isothermal helicase dependent amplification

Indexed keywords

GENOMIC DNA; HEMOGLOBIN BETA CHAIN;

ARTICLE; CANCER CELL; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; ISOTHERMAL HELICASE DEPENDENT AMPLIFICATION; LIMIT OF DETECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VALIDITY; VIRUS DETECTION; EVALUATION STUDY; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MASS SCREENING; MOLECULAR DIAGNOSIS; NUCLEIC ACID AMPLIFICATION; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; TEMPERATURE; VIROLOGY;

FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MASS SCREENING; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; TEMPERATURE;

EID: 84900474486     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.02.012     Document Type: Article

References (10)

1. Andresen D., von Nickisch-Rosenegk M., Bier F.F. Helicase dependent OnChip-amplification and its use in multiplex pathogen detection. Clin Chim Acta 2009, 403:244-248.
2. Artiushin S., Tong Y., Timoney J., Lemieux B., Schlegel A., Kong H. Thermophilic helicase-dependent DNA amplification using the IsoAmp™ SE experimental kit for rapid detection of Streptococcus equi subspecies equi in clinical samples. J Vet Diagn Invest 2011, 23:909-914.
3. Bzhalava D., Guan P., Franceschi S., Dillner J., Clifford G. A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology 2013, 445:224-231.
4. Defilippis V.R., Ayala F.J., Villarreal L.P. Evidence of diversifying selection in human papillomavirus type 16 E6 but not E7 oncogenes. J Mol Evol 2002, 55:491-499.
5. Doseeva V., Forbes T., Wolff J., Khripin Y., O'neil D., Rothmann T., Nazarenko I. Multiplex isothermal helicase-dependent amplification assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. Diagn Microbiol Infect Dis 2011, 71:354-365.
6. Forman D., de Martel C., Lacey C.J., Soerjomataram I., Lortet-Tieulent J., Bruni L., Vignat J., Ferlay J., Bray F., Plummer M., Franceschi S. Global burden of human papillomavirus and related diseases. Vaccine 2012, 30(Suppl 5):F12-F23.
7. Garbuglia A.R., Carletti F., Minosse C., Piselli P., Zaniratti M.S., Serraino D., Capobianchi M.R. Genetic variability in E6 and E7 genes of human papillomavirus -16, -18, -31 and -33 from HIV-1-positive women in Italy. New Microbiol 2007, 30:377-382.
8. Pett M., Coleman N. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?. J Pathol 2007, 212:356-367.
9. Poljak M., Kocjan B.J. Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert Rev Anti Infect Ther 2010, 8:1139-1162.
10. Sichero L., Simão Sobrinho J., Lina Villa L. Oncogenic potential diverge among human papillomavirus type 16 natural variants. Virology 2012, 432:127-132.